Validating Automatic Diadochokinesis Analysis Methods Across Dysarthria Severity and Syllable Task in Amyotrophic Lateral Sclerosis.


Journal

Journal of speech, language, and hearing research : JSLHR
ISSN: 1558-9102
Titre abrégé: J Speech Lang Hear Res
Pays: United States
ID NLM: 9705610

Informations de publication

Date de publication:
08 03 2022
Historique:
pubmed: 17 2 2022
medline: 26 3 2022
entrez: 16 2 2022
Statut: ppublish

Résumé

Oral diadochokinesis (DDK) is a standard dysarthria assessment task. To extract automatic and semi-automatic DDK measurements, numerous DDK analysis algorithms based on acoustic signal processing are available, including amplitude based, spectral based, and hybrid. However, these algorithms have been predominantly validated in individuals with no perceptible to mild dysarthria. The behavior of these algorithms across dysarthria severity is largely unknown. Likewise, these algorithms have not been tested equally for various syllable types. The goal of this study was to evaluate the performance of five common DDK algorithms as a function of dysarthria severity, considering syllable types. We analyzed 282 DDK recordings of /ba/, /pa/, and /ta/ from 145 participants with amyotrophic lateral sclerosis. Recordings were stratified into mild, moderate, or severe dysarthria groups based on individual performance on the Speech Intelligibility Test. Analysis included manual and automatic estimation of the number of syllables, DDK rate, and cycle-to-cycle temporal variability (cTV). Validation metrics included Bland-Altman mixed-effects limits of agreement between manual and automatic syllable counts, recall and precision between manual and automatic syllable boundary detection, and Kendall's tau-b correlations between manual and algorithm-detected DDK rate and cTV. The amplitude-based algorithm (absolute energy) yielded the strongest correlations with manual analysis across all severity groups for DDK rate ( Algorithms based on signal energy analysis appeared to be the most robust for DDK analysis across dysarthria severity and syllable types; however, it remains prone to error against severe dysarthria and alveolar syllable context. Further development is needed to address this important issue.

Identifiants

pubmed: 35171700
doi: 10.1044/2021_JSLHR-21-00503
pmc: PMC9150739
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

940-953

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC009890
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC017291
Pays : United States

Références

Amyotroph Lateral Scler Frontotemporal Degener. 2020 Feb;21(1-2):34-41
pubmed: 31694409
Workshop Speech Lang Process Assist Technol. 2016 Sep;2016:91-97
pubmed: 29423454
Turk J Emerg Med. 2018 Aug 07;18(3):91-93
pubmed: 30191186
J Commun Disord. 1999 May-Jun;32(3):141-80, 183-6; quiz 181-3, 187-9
pubmed: 10382143
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Amyotroph Lateral Scler Frontotemporal Degener. 2020 Feb;21(1-2):42-50
pubmed: 32138555
Neurology. 1999;53(8 Suppl 5):S22-5; discussion S35-6
pubmed: 10560633
PLoS One. 2016 May 05;11(5):e0154971
pubmed: 27148967
J Speech Lang Hear Res. 2020 Oct 16;63(10):3453-3460
pubmed: 32955982
PLoS One. 2015 Mar 04;10(3):e0118432
pubmed: 25738806
J Speech Lang Hear Res. 2018 Nov 8;61(11):2757-2771
pubmed: 30383220
Front Neurol. 2019 Feb 19;10:106
pubmed: 30837936
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):494-500
pubmed: 23898888
J Speech Hear Res. 1991 Dec;34(6):1269-75
pubmed: 1787708
IEEE EMBS Int Conf Biomed Health Inform. 2019;2019:1-4
pubmed: 32864624
J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1093-8
pubmed: 1783924
Chaos. 2005 Sep;15(3):33903
pubmed: 16252994
J Speech Lang Hear Res. 2016 Oct 1;59(5):887-899
pubmed: 27679842
Chaos. 1995 Mar;5(1):30-34
pubmed: 12780151
PLoS One. 2016 Dec 14;11(12):e0168321
pubmed: 27973556
J Speech Hear Disord. 1981 Aug;46(3):296-301
pubmed: 7278175
Front Neurol. 2019 Dec 05;10:1288
pubmed: 31866935
Otolaryngol Head Neck Surg. 2005 Mar;132(3):500-4
pubmed: 15746870
J Speech Hear Res. 1995 Apr;38(2):304-14
pubmed: 7596096
Folia Phoniatr Logop. 2009;61(1):1-11
pubmed: 19088478
BMC Med Res Methodol. 2020 Jun 12;20(1):154
pubmed: 32532218
Lancet. 2011 Mar 12;377(9769):942-55
pubmed: 21296405
J Speech Lang Hear Res. 2019 Jan 22;63(1):59-73
pubmed: 31940257
IEEE Trans Neural Syst Rehabil Eng. 2020 Jan;28(1):32-41
pubmed: 31545738

Auteurs

Chelsea Tanchip (C)

Department of Speech-Language Pathology, Rehabilitation Sciences Institute, University of Toronto, Ontario, Canada.

Diego L Guarin (DL)

Department of Biomedical Engineering, Florida Institute of Technology, Melbourne.

Scotia McKinlay (S)

Department of Speech-Language Pathology, Rehabilitation Sciences Institute, University of Toronto, Ontario, Canada.

Carolina Barnett (C)

Division of Neurology, Department of Medicine, University of Toronto and University Health Network, Ontario, Canada.

Sanjay Kalra (S)

Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada.
Division of Neurology, University of Alberta, Edmonton, Canada.

Angela Genge (A)

Clinical Research Unit, Montreal Neurological Institute & Hospital, and Department of Neurology and Neurosurgery, McGill University, Québec, Canada.

Lawrence Korngut (L)

Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada.

Jordan R Green (JR)

Department of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA.

James Berry (J)

Department of Neurology, Massachusetts General Hospital, Boston.

Lorne Zinman (L)

Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Azadeh Yadollahi (A)

KITE, Toronto Rehabilitation Institute, University Health Network, Ontario, Canada.
Institute of Biomedical Engineering, University of Toronto, Ontario, Canada.

Agessandro Abrahao (A)

Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Yana Yunusova (Y)

Department of Speech-Language Pathology, Rehabilitation Sciences Institute, University of Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
KITE, Toronto Rehabilitation Institute, University Health Network, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH